2026-W46 · Nov 9–Nov 15 · Company · Profile · published
Altria Group company profile · smokeable & oral tobacco · history · financial snapshot · S&P 500 rank #92 · 奧馳亞集團業務歷史財務與標普500地位
SNAPSHOT
| Ticker | MO (NYSE) |
| Company | Altria Group, Inc. |
| GICS sector / industry | Consumer Staples (XLP) / Tobacco |
| S&P 500 rank (by weight) | #92 · 0.18% (Oct 29, 2026) |
| Sector rank (by market cap) | #7 in Consumer Staples (Oct 29, 2026) |
| Headquarters | Richmond, Virginia |
| Founded | 1985 (as Philip Morris Companies Inc., the holding company) |
| CEO | Billy Gifford (since April 2020) |
| Employees | Not available |
| Market cap | $128.15B (Oct 29, 2026; price $76.75) |
| SEC filings | EDGAR — CIK 0000764180 |
WHAT IT DOES
Altria is America's largest tobacco company, selling cigarettes and cigars through Philip Morris USA and John Middleton, and smokeless tobacco and oral nicotine pouches through U.S. Smokeless Tobacco and Helix. It also holds large equity investments in Anheuser-Busch InBev and Cronos. FY2025 net revenues were $23.28B, down 3.1%, and revenues net of excise taxes were $20.14B.
Smokeable products ($20.49B) still dominate, led by Marlboro, the best-selling US cigarette brand, but the volume trend is structural decline: domestic cigarette shipment volume fell 10.0% in 2025 to 61.8 billion units, as smokers quit, switch or trade to illicit and alternative products. Pricing power — raising prices faster than volumes fall — is what keeps smokeable profit growing despite shrinking units.
Oral tobacco ($2.80B) is the growth bet: Copenhagen and Skoal smokeless products plus on! nicotine pouches, aimed at adult smokers moving away from combustibles. E-vapor (NJOY) took large non-cash impairments in 2025 and was removed as a reportable segment in early 2026, a reminder that the smoke-free transition is expensive and uncertain even for the incumbent.
BUSINESS SEGMENTS — FY2025 REVENUE
| Segment | Revenue | Share | YoY |
|---|---|---|---|
| Smokeable products | $20.49B | 88.0% | Not available |
| Oral tobacco products | $2.80B | 12.0% | Not available |
| All other | −$0.01B | −0.0% | Not available |
| Total net revenues | $23.28B | 100% | −3.1% |
HISTORY
| Year | Milestone |
|---|---|
| 1822 | Philip Morris opens a London tobacco shop, the origin of the Philip Morris name |
| 1919 | Philip Morris & Co. incorporated in the United States |
| 1954 | Marlboro relaunched as a filtered cigarette; it becomes the US best-seller |
| 1985 | Philip Morris Companies Inc. formed as the holding company |
| 2003 | Philip Morris Companies renamed Altria Group, Inc. |
| 2008 | Philip Morris International spun off, leaving Altria with the US business |
| 2009 | Acquires UST Inc., adding Copenhagen and Skoal smokeless brands |
| 2019 | Invests in JUUL Labs; the stake is later written down substantially |
| 2023 | Acquires NJOY, entering the e-vapor category |
| 2025 | E-vapor takes large non-cash impairments; cigarette volume falls 10.0% |
COMPETITIVE POSITION
FINANCIAL SNAPSHOT — FY2025
| Net revenues | $23.28B (−3.1% YoY) |
| Revenues net of excise taxes | $20.14B (−1.5% YoY) |
| Net earnings | $6.95B |
| Reported diluted EPS | $4.12 (−37.0% YoY, vs a 2024 IQOS-rights gain) |
| Adjusted diluted EPS | $5.42 (+4.4% YoY) |
| Domestic cigarette volume | 61.8 billion units (−10.0% YoY) |
| Oral tobacco shipment volume | 732.4 million cans (−5.5% YoY) |
KEY RISKS
WHY IT MATTERS FOR THE S&P 500
Altria is the S&P 500's tobacco income play: at a 0.18% index weight and the #7 market cap in Consumer Staples, it is the index's main exposure to US tobacco cash flows, pricing power and the economics of a declining but highly profitable category.
Its volume, pricing and smoke-free mix are read as the real-time state of the US nicotine market — 61.8 billion cigarettes shipped in 2025, down 10.0%, against a growing oral portfolio — and its dividend capacity is a test of how long a shrinking category can fund shareholder returns.
SOURCES & METHODOLOGY
| Market data | Slickcharts S&P 500 by weight (rank, weight, price — Oct 29, 2026 close) |
| Financials | Altria FY2025 Form 10-K (SEC EDGAR, filed Feb 25, 2026; fiscal year ended Dec 31, 2025) |
| Sector classification | GICS (Tobacco) via the List of S&P 500 companies (Wikipedia) |
| Library data | SPXSet logo library, compiled from company official websites, filings, or Wikipedia; as company logos are dynamic corporate information, no 100% guarantee is made for the graphics. SPXSet chart library, monthly bars, compiled from Yahoo public information. |
Source: Yahoo Finance monthly bars, split-adjusted · Data as of Sep 30, 2026 (last closed month) · SPXSet.com
FINANCIALS
公司快照
| 代碼 | MO(NYSE) |
| 公司 | Altria Group, Inc. |
| GICS 板塊/行業 | 必需消費品(XLP)/煙草 |
| 標普500排名(按權重) | #92 · 0.18%(2026 年 10 月 29 日) |
| 板塊內排名(按市值) | 必需消費品第 #7(2026 年 10 月 29 日) |
| 總部 | 美國弗吉尼亞州里士滿 |
| 成立 | 1985 年(原名 Philip Morris Companies Inc.,控股公司) |
| 行政總裁 | Billy Gifford(自 2020 年 4 月) |
| 員工 | Not available |
| 市值 | $128.15B(2026 年 10 月 29 日;價格 $76.75) |
| SEC 申報 | EDGAR — CIK 0000764180 |
業務概覽
奧馳亞是美國最大的煙草公司,經 Philip Morris USA 與 John Middleton 銷售香煙與雪茄,經 U.S. Smokeless Tobacco 與 Helix 銷售無煙煙草與口含尼古丁袋;另持有 Anheuser-Busch InBev 與 Cronos 的大額股權投資。FY2025 淨收入為 $23.28B,下跌 3.1%,扣除消費稅後收入為 $20.14B。
可燃煙草產品($20.49B)仍佔主導,以美國最暢銷香煙品牌 Marlboro 為首,但銷量趨勢是結構性下滑:2025 年國內香煙出貨量下跌 10.0% 至 618 億支,因吸煙者戒煙、轉用或轉向非法與替代產品。定價能力——加價快於銷量下跌——是令可燃利潤在單位萎縮下仍能增長的原因。
口含煙草($2.80B)是增長賭注:Copenhagen 與 Skoal 無煙產品加上 on! 尼古丁袋,瞄準遠離可燃產品的成年吸煙者。電子煙(NJOY)在 2025 年計提大額非現金減值,並於 2026 年初不再列為報告板塊,提醒即使是 incumbent,走向無煙的轉型亦代價高昂且充滿不確定性。
業務板塊 — FY2025 收入
| 板塊 | 收入 | 佔比 | 同比 |
|---|---|---|---|
| 可燃煙草產品 | $20.49B | 88.0% | Not available |
| 口含煙草產品 | $2.80B | 12.0% | Not available |
| 所有其他 | −$0.01B | −0.0% | Not available |
| 淨收入總額 | $23.28B | 100% | −3.1% |
歷史沿革
| 年份 | 里程碑 |
|---|---|
| 1822 | Philip Morris 在倫敦開設煙草店,為 Philip Morris 之名的源頭 |
| 1919 | Philip Morris & Co. 在美國註冊成立 |
| 1954 | Marlboro 以過濾嘴香煙重新推出,後成為美國最暢銷品牌 |
| 1985 | Philip Morris Companies Inc. 成立為控股公司 |
| 2003 | Philip Morris Companies 更名為 Altria Group, Inc. |
| 2008 | Philip Morris International 分拆,奧馳亞保留美國業務 |
| 2009 | 收購 UST Inc.,加入 Copenhagen 與 Skoal 無煙品牌 |
| 2019 | 投資 JUUL Labs;該持股其後大幅減值 |
| 2023 | 收購 NJOY,進入電子煙品類 |
| 2025 | 電子煙計提大額非現金減值;香煙銷量下跌 10.0% |
競爭地位
財務快照 — FY2025
| 淨收入 | $23.28B(同比 −3.1%) |
| 扣除消費稅後收入 | $20.14B(同比 −1.5%) |
| 淨利潤 | $6.95B |
| 報告攤薄每股盈利 | $4.12(同比 −37.0%,因 2024 年 IQOS 權利出售收益) |
| 經調整攤薄每股盈利 | $5.42(同比 +4.4%) |
| 國內香煙銷量 | 618 億支(同比 −10.0%) |
| 口含煙草出貨量 | 7.324 億罐(同比 −5.5%) |
主要風險
對標普500的重要性
奧馳亞是標普500的煙草收益標的:指數權重 0.18%、必需消費品板塊市值第 #7,是指數對美國煙草現金流、定價能力,以及一個萎縮但利潤極高品類的經濟學的主要敞口。
其銷量、定價與無煙組合,是美國尼古丁市場的即時狀態——2025 年香煙出貨 618 億支,下跌 10.0%,口含產品組合則在增長——而其派息能力,則考驗一個萎縮品類能為股東回報供資多久。
來源與方法
| 市場數據 | Slickcharts 標普500權重榜(排名、權重、價格——2026 年 10 月 29 日收盤) |
| 財務 | 奧馳亞 FY2025 Form 10-K(SEC EDGAR,2026 年 2 月 25 日申報;財政年度截至 2025 年 12 月 31 日) |
| 板塊分類 | GICS(煙草),據 S&P 500 公司清單(Wikipedia) |
| 圖庫數據 | SPXSet logo 庫,整理自企業官方網站、文件或維基百科;由於是企業自身動態資訊,不對圖形做百分百保證。SPXSet 圖表庫月線,整理自 Yahoo 公開資訊。 |
來源:Yahoo Finance 月 K(經拆股調整)· 數據截至 2026 年 9 月 30 日(最後已收月份) · SPXSet.com
財報
SPXSet in-house research — market structure, options and volatility. Not investment advice.
SPXSet 站內獨立研究,聚焦 SPX 市場結構、期權與波動率;內容不構成投資建議。
Entered 2026-10-30 05:05 · updated 2026-11-14 23:30 · rev 7